2033 ORAL Improved chemotherapy delivery in breast cancer patients receiving pegfilgrastim primary prophylaxis compared with current practice neutropenia management – results from an integrated analysis (NeuCuP)
Publication
, Conference
Aapro, M; Schwenkglenks, M; Lyman, G; Lopez-Pousa, A; Easton, V; Skacel, T; Von Minckwitz, G
Published in: European Journal of Cancer Supplements
September 2007
Duke Scholars
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
September 2007
Volume
5
Issue
4
Start / End Page
194 / 194
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Aapro, M., Schwenkglenks, M., Lyman, G., Lopez-Pousa, A., Easton, V., Skacel, T., & Von Minckwitz, G. (2007). 2033 ORAL Improved chemotherapy delivery in breast cancer patients receiving pegfilgrastim primary prophylaxis compared with current practice neutropenia management – results from an integrated analysis (NeuCuP). In European Journal of Cancer Supplements (Vol. 5, pp. 194–194). Elsevier BV. https://doi.org/10.1016/s1359-6349(07)70795-4
Aapro, M., M. Schwenkglenks, G. Lyman, A. Lopez-Pousa, V. Easton, T. Skacel, and G. Von Minckwitz. “2033 ORAL Improved chemotherapy delivery in breast cancer patients receiving pegfilgrastim primary prophylaxis compared with current practice neutropenia management – results from an integrated analysis (NeuCuP).” In European Journal of Cancer Supplements, 5:194–194. Elsevier BV, 2007. https://doi.org/10.1016/s1359-6349(07)70795-4.
Aapro M, Schwenkglenks M, Lyman G, Lopez-Pousa A, Easton V, Skacel T, et al. 2033 ORAL Improved chemotherapy delivery in breast cancer patients receiving pegfilgrastim primary prophylaxis compared with current practice neutropenia management – results from an integrated analysis (NeuCuP). In: European Journal of Cancer Supplements. Elsevier BV; 2007. p. 194–194.
Aapro, M., et al. “2033 ORAL Improved chemotherapy delivery in breast cancer patients receiving pegfilgrastim primary prophylaxis compared with current practice neutropenia management – results from an integrated analysis (NeuCuP).” European Journal of Cancer Supplements, vol. 5, no. 4, Elsevier BV, 2007, pp. 194–194. Crossref, doi:10.1016/s1359-6349(07)70795-4.
Aapro M, Schwenkglenks M, Lyman G, Lopez-Pousa A, Easton V, Skacel T, Von Minckwitz G. 2033 ORAL Improved chemotherapy delivery in breast cancer patients receiving pegfilgrastim primary prophylaxis compared with current practice neutropenia management – results from an integrated analysis (NeuCuP). European Journal of Cancer Supplements. Elsevier BV; 2007. p. 194–194.
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
September 2007
Volume
5
Issue
4
Start / End Page
194 / 194
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis